Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Esteem Bio IPO.
March 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechMarch 28, 2024 4:45:00 PM
Boundless Bio�s research into what drives this phenomenon has yielded new understanding of cancer biology. The company now has $100 million in IPO cash to support two programs in early clinical ...
Published by : MedCity NewsApril 18, 2024 9:46:00 PM
Ibotta began its path as a public company on Thursday by opening at $117 per share, a big increase from its IPO price of $88, itself an increase from its proposed range of $76 to $84 per share.
Published by : TechCrunchMarch 27, 2024 2:30:00 PM
BOUNDLESS BIO, INC BOLD IPO will take place March, 28 on the NASDAQ exchange under the ticker BOLD. The company is offering shares at an expected price between $15.00 and $17.00 per share with an ...
Published by : Benzinga.comApril 18, 2024 3:30:00 AM
Spencer Platt / Staff / Getty Images Loar Holdings plans to raise up to $286 million by offering 11 million shares at $24 to $26 per share in its initial public offering (IPO), according to a ...
Published by : InvestopediaApril 18, 2024 3:44:00 AM
Ibotta and shareholders sold 6.56 million shares for $88 each, Bloomberg reported, exceeding the company�s estimated IPO price, which was put between $76 and $84. Selling the shares for $88 each ...
Published by : ForbesMarch 28, 2024 3:31:00 AM
Boundless Bio, a cancer drug developer backed by Bayer ... ending a short break in biotech IPO activity. Still, new stock issuances have now totaled $1.3 billion in 2024, the most for the sector ...
Published by : Yahoo FinanceMarch 28, 2024 10:21:00 PM
Bayer Healthcare (OTCPK:BAYZF) (OTCPK:BAYRY) held a 9% stake in the company ahead of the IPO. Based in San Diego, Boundless Bio is developing ecDNA-directed therapeutics called ecDTx along with a ...
Published by : Seeking AlphaMarch 25, 2024 6:55:00 PM
The IPO market has been red hot lately, with companies like chipmaker Astera Labs (ALAB) and social media platform Reddit (RDDT) making their debuts through initial public offerings. Astera Labs ...
Published by : Seeking AlphaApril 2, 2024 3:30:00 AM
UL Solutions filed for an initial public offering (IPO) Tuesday, aiming to raise up to $812 million. UL Solutions, which provides safety-focused testing, inspection, and certification services ...
Published by : InvestopediaEsteem Bio Organic Food Processing Ltd is entering in the capital markets (through BSE SME) with an initial public offering, IPO of 45,00,000 Equity Shares of Rs 10/- each. The price for the issue has been fixed at Rs 25/- per share.
Incorporated in 1995, Esteem Bio Organic Food Processing Ltd is engaged in to agriculture operations. Company cultivates wheat, paddy, sugar cane, fruits, vegetables, flowers and also engaged in wood plantation. Esteem Bio have an integrated facility of cultivation, processing and distribution of agriculture commodities.
The issue opens on Jan 18, 2013 and closes for subscription on Jan 22, 2013. The equity shares of the issue are proposed to be listed on the SME Platform of BSE Limited.
The Esteem Bio IPO is proposed to open on January 18, 2013. The IPO application ends on January 22, 2013.
Retail investors can apply in the retail or non-institutional investor category from January 18, 2013 to January 22, 2013. The Esteem Bio IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Esteem Bio IPO will open for subscription on January 18, 2013. The public issue will close on January 22, 2013.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
DRHP
